Clinical Trial Update: Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX) [NA]

View source ↗

Summary

A terminated feasibility study evaluating beta-adrenergic blockade in cervical cancer; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cervical Cancer | NA | Status: TERMINATED | Results posted: 2021-10-12